Research programme: atherosclerosis therapeutics - PhosphagenicsAlternative Names: APA-01; APA-02; Tocopherol derivatives
Latest Information Update: 19 Jan 2011
At a glance
- Originator Phosphagenics
- Class Tocopherols
- Mechanism of Action Antioxidants; Free radical scavengers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Atherosclerosis